| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.
Over the last 12 months, insiders at Enlivex Therapeutics Ltd. have bought $0 and sold $0 worth of Enlivex Therapeutics Ltd. stock.
On average, over the past 5 years, insiders at Enlivex Therapeutics Ltd. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2015-10-09 | Sale | Murray Michael Anthony | former SVP - Operations | 56,390 0.6424% | $2.78 | $156,764 | -52.92% |
| Increased Positions | 15 | +50% | 814,478 | +116.67% |
| Decreased Positions | 11 | -36.67% | 189,985 | -27.21% |
| New Positions | 5 | New | 121,917 | New |
| Sold Out Positions | 9 | Sold Out | 144,636 | Sold Out |
| Total Postitions | 34 | +13.33% | 1M | +89.46% |
| Morgan Stanley | $131.00 | 0.07% | 173,625 | -45,524 | -20.77% | 2025-09-30 |
| Renaissance Technologies Llc | $119.00 | 0.07% | 157,292 | -11,100 | -6.59% | 2025-09-30 |
| Citadel Advisors Llc | $52.00 | 0.03% | 68,936 | +68,936 | New | 2025-09-30 |
| Susquehanna International Group, Llp | $41.00 | 0.02% | 54,850 | +54,850 | New | 2025-09-30 |
| Xtx Topco Ltd | $32.00 | 0.02% | 42,668 | +42,668 | New | 2025-09-30 |
| Two Sigma Securities, Llc | $26.00 | 0.01% | 34,242 | +34,242 | New | 2025-09-30 |
| Sigma Investment Counselors Inc | $21.00 | 0.01% | 28,000 | 0 | 0% | 2025-09-30 |
| Jane Street Group, Llc | $16.00 | 0.01% | 21,529 | -39,523 | -64.74% | 2025-09-30 |
| Hrt Financial Lp | $14.00 | 0.01% | 18,792 | +18,792 | New | 2025-09-30 |
| Prosperity Consulting Group, Llc | $13.00 | 0.01% | 17,647 | +17,647 | New | 2025-09-30 |